ONCYNasdaqPharmaceutical PreparationsFiscal year ends December 31
ONCOLYTICS BIOTECH INC
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 10-Q on Aug 12, 2026
$0.50−0.00 (-0.36%)
Close on Oct 19, 2026
Share price
−$0.6837 (−57.94%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- –
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Diluted shares
- 120M
Valuation needs the share price. It fills in once daily prices are connected and converted from CAD.
Twelve years at a glance
Fiscal years 2014 to 2025, CAD
Revenue
–
Operating income
–
EPS, diluted
–
Reported period